312 related articles for article (PubMed ID: 25319937)
1. Clearance of glucoregulatory peptide hormones during haemodialysis and haemodiafiltration in non-diabetic end-stage renal disease patients.
Jørgensen MB; Idorn T; Knop FK; Holst JJ; Hornum M; Feldt-Rasmussen B
Nephrol Dial Transplant; 2015 Mar; 30(3):513-20. PubMed ID: 25319937
[TBL] [Abstract][Full Text] [Related]
2. Postprandial responses of incretin and pancreatic hormones in non-diabetic patients with end-stage renal disease.
Idorn T; Knop FK; Jørgensen M; Holst JJ; Hornum M; Feldt-Rasmussen B
Nephrol Dial Transplant; 2014 Jan; 29(1):119-27. PubMed ID: 24078334
[TBL] [Abstract][Full Text] [Related]
3. Influence of hemodialysis on incretin hormones and insulin secretion in diabetic and non-diabetic patients.
Masajtis-Zagajewska A; Kurnatowska I; Wajdlich M; Jagodzińska M; Nowicki M
Int Urol Nephrol; 2013 Dec; 45(6):1733-40. PubMed ID: 23670285
[TBL] [Abstract][Full Text] [Related]
4. Increased postprandial GIP and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects.
Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
J Clin Endocrinol Metab; 2011 Feb; 96(2):447-53. PubMed ID: 21047927
[TBL] [Abstract][Full Text] [Related]
5. Expected values for gastrointestinal and pancreatic hormone concentrations in healthy volunteers in the fasting and postprandial state.
Meek CL; Lewis HB; Burling K; Reimann F; Gribble F
Ann Clin Biochem; 2021 Mar; 58(2):108-116. PubMed ID: 33175577
[TBL] [Abstract][Full Text] [Related]
6. Elimination and degradation of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with end-stage renal disease.
Idorn T; Knop FK; Jørgensen MB; Christensen M; Holst JJ; Hornum M; Feldt-Rasmussen B
J Clin Endocrinol Metab; 2014 Jul; 99(7):2457-66. PubMed ID: 24712563
[TBL] [Abstract][Full Text] [Related]
7. Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in people with and without type 2 diabetes.
Alsalim W; Tura A; Pacini G; Omar B; Bizzotto R; Mari A; Ahrén B
Diabetes Obes Metab; 2016 Jan; 18(1):24-33. PubMed ID: 26354383
[TBL] [Abstract][Full Text] [Related]
8. Circulating concentrations of glucagon-like peptide 1, glucose-dependent insulinotropic peptide, peptide YY, and insulin in client-owned lean, overweight, and diabetic cats.
McMillan CJ; Zapata RC; Chelikani PK; Snead EC; Cosford K
Domest Anim Endocrinol; 2016 Jan; 54():85-94. PubMed ID: 26609567
[TBL] [Abstract][Full Text] [Related]
9. Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects.
Knop FK; Konings E; Timmers S; Schrauwen P; Holst JJ; Blaak EE
Diabet Med; 2013 Oct; 30(10):1214-8. PubMed ID: 23663119
[TBL] [Abstract][Full Text] [Related]
10. Effect of the Incretin Hormones on the Endocrine Pancreas in End-Stage Renal Disease.
Jørgensen MB; Idorn T; Rydahl C; Hansen HP; Bressendorff I; Brandi L; Wewer Albrechtsen NJ; van Hall G; Hartmann B; Holst JJ; Knop FK; Hornum M; Feldt-Rasmussen B
J Clin Endocrinol Metab; 2020 Jan; 105(1):. PubMed ID: 31608934
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease.
Idorn T; Knop FK; Jørgensen M; Holst JJ; Hornum M; Feldt-Rasmussen B
Kidney Int; 2013 May; 83(5):915-23. PubMed ID: 23325073
[TBL] [Abstract][Full Text] [Related]
12. High-efficiency on-line haemodiafiltration improves conduit artery endothelial function compared with high-flux haemodialysis in end-stage renal disease patients.
Bellien J; Fréguin-Bouilland C; Joannidès R; Hanoy M; Rémy-Jouet I; Monteil C; Iacob M; Martin L; Renet S; Vendeville C; Godin M; Thuillez C; Le Roy F
Nephrol Dial Transplant; 2014 Feb; 29(2):414-22. PubMed ID: 24235073
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal motility in patients with end-stage renal disease on chronic hemodialysis.
Broberg B; Madsen JL; Fuglsang S; Holst JJ; Christensen KB; Rydahl C; Idorn T; Feldt-Rasmussen B; Hornum M
Neurogastroenterol Motil; 2019 Apr; 31(4):e13554. PubMed ID: 30667131
[TBL] [Abstract][Full Text] [Related]
14. Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients.
Tsuchimochi W; Ueno H; Yamashita E; Tsubouchi C; Sakoda H; Nakamura S; Nakazato M
Endocr J; 2015; 62(1):13-20. PubMed ID: 25252844
[TBL] [Abstract][Full Text] [Related]
15. Effects of consumption of main and side dishes with white rice on postprandial glucose, insulin, glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 responses in healthy Japanese men.
Kameyama N; Maruyama C; Matsui S; Araki R; Yamada Y; Maruyama T
Br J Nutr; 2014 May; 111(9):1632-40. PubMed ID: 24507870
[TBL] [Abstract][Full Text] [Related]
16. Incretin and islet hormone responses to meals of increasing size in healthy subjects.
Alsalim W; Omar B; Pacini G; Bizzotto R; Mari A; Ahrén B
J Clin Endocrinol Metab; 2015 Feb; 100(2):561-8. PubMed ID: 25375983
[TBL] [Abstract][Full Text] [Related]
17. Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1.
Sonne DP; Rehfeld JF; Holst JJ; Vilsbøll T; Knop FK
Eur J Endocrinol; 2014 Oct; 171(4):407-19. PubMed ID: 24986531
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes.
Thomsen C; Storm H; Holst JJ; Hermansen K
Am J Clin Nutr; 2003 Mar; 77(3):605-11. PubMed ID: 12600850
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels of advanced glycation end products during haemodialysis, haemodiafiltration and haemofiltration: potential importance of dialysate quality.
Gerdemann A; Wagner Z; Solf A; Bahner U; Heidland A; Vienken J; Schinzel R
Nephrol Dial Transplant; 2002 Jun; 17(6):1045-9. PubMed ID: 12032195
[TBL] [Abstract][Full Text] [Related]
20. Impact of exogenous hyperglucagonemia on postprandial concentrations of gastric inhibitory polypeptide and glucagon-like peptide-1 in humans.
Meier JJ; Ritter PR; Jacob A; Menge BA; Deacon CF; Schmidt WE; Nauck MA; Holst JJ
J Clin Endocrinol Metab; 2010 Aug; 95(8):4061-5. PubMed ID: 20501678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
